Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
source: pixabay.com

Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer

According to a story from ANCA Vasculitis News, the biopharmaceutical company ChemoCentryx has recently made an amendment to its approval application for its investigational therapy. This therapy, called avacopan, is…

Continue Reading Approval Application for ANCA-Associated Vasculitis Drug Amended by Developer
CRISPR-Cas9’s Latest Genome Editing Feat: Stem Cells That Deliver Drugs in Response to Inflammation
source: pixabay.com

CRISPR-Cas9’s Latest Genome Editing Feat: Stem Cells That Deliver Drugs in Response to Inflammation

  Genetic Engineering and Biotechnology News recently published an article describing how engineered cells were implanted into rheumatoid mouse models. The cells used in the study were able to sense…

Continue Reading CRISPR-Cas9’s Latest Genome Editing Feat: Stem Cells That Deliver Drugs in Response to Inflammation